Studies from AstraZeneca Update Current Data on COVID-19 (Azd3152 Neutralizes Sars-cov-2 Historical and Contemporary Variants and Is Protective In Hamsters and Well Tolerated In Adults)

Source :: Pharma Business Week. July 22, 2024, 427
Publication Year :: 2024
Abstract: 2024 JUL 22 (NewsRx) -- By a News Reporter-Staff News Editor at Pharma Business Week -- Investigators publish new report on Coronavirus - COVID-19. According to news reporting from Gaithersburg, [...]

Subjects :: AstraZeneca PLC
Adults -- Health aspects -- Research
Severe acute respiratory syndrome -- Research
Monoclonal antibodies -- Research
Coronaviruses -- Health aspects -- Research
Pharmaceutical industry -- Health aspects -- Research
Hamsters -- Health aspects -- Research
Business
Pharmaceuticals and cosmetics industries
Health

Tools